Kommittén befarade att huvudstudien hade omfattat ett antal patienter som skulle kunna ha fått intensiv kemoterapi och att detta kanske medfört att Evoltras effekt sett mer lovande ut. ###>The Committee was concerned that the main study included a number of patients who could have been suitable for intensive chemotherapy and this could have made the effectiveness of Evoltra look more promising.